Clopidogrel resistance: a new chapter in a fast-moving story

Circulation. 2004 Jun 29;109(25):3064-7. doi: 10.1161/01.CIR.0000134701.40946.30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angioplasty
  • Angioplasty, Balloon, Coronary
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Aspirin / administration & dosage
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Disease / blood
  • Coronary Disease / drug therapy*
  • Coronary Disease / therapy
  • Dose-Response Relationship, Drug
  • Drug Resistance
  • Drug Therapy, Combination
  • Eptifibatide
  • Heparin / administration & dosage
  • Heparin / therapeutic use
  • Humans
  • Peptides / administration & dosage
  • Peptides / therapeutic use
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Stents
  • Thromboxane A2 / biosynthesis
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / pharmacology*
  • Ticlopidine / therapeutic use
  • Treatment Outcome

Substances

  • Anticoagulants
  • Peptides
  • Platelet Aggregation Inhibitors
  • Thromboxane A2
  • Heparin
  • Clopidogrel
  • Eptifibatide
  • Ticlopidine
  • Aspirin